Symptoms, Diagnosis, Treatment & Prognosis
Complete guide to soft tissue sarcoma in dogs — symptoms, diagnosis, treatment options, costs, and prognosis.
Soft tissue sarcoma in dogs is a broad category of malignant tumors that arise from connective tissues — including fat, muscle, nerves, fibrous tissue, and blood vessels. These tumors account for approximately 8–15% of all canine skin and subcutaneous tumors, according to the Merck Veterinary Manual. Unlike some aggressive cancers that spread rapidly, most soft tissue sarcomas are locally invasive, meaning they grow into surrounding tissue but have a relatively low to moderate metastatic rate (10–30%, depending on tumor grade). However, their tendency to recur after incomplete surgical removal makes them a serious diagnosis that demands prompt veterinary attention.
Because soft tissue sarcomas often present as seemingly benign lumps under the skin, many owners delay seeking care. This guide covers everything you need to know — from early warning signs to treatment costs — so you can act quickly and advocate effectively for your dog.
What Is Soft Tissue Sarcoma in Dogs?
Soft tissue sarcoma (STS) is not a single disease but an umbrella term for cancers originating from mesenchymal (connective) cells. Common subtypes found in dogs include:
- Fibrosarcoma — arises from fibrous connective tissue
- Peripheral nerve sheath tumor (PNST) — develops from nerve coverings
- Hemangiopericytoma — originates from blood vessel support cells
- Liposarcoma — develops from fat cells (rare compared to benign lipomas)
- Leiomyosarcoma — arises from smooth muscle
- Myxosarcoma — develops from primitive connective tissue
- Undifferentiated sarcoma — cells cannot be traced to a specific tissue type
What makes STS particularly tricky is that many of these tumors feel identical to benign growths like lipomas (fatty tumors) or cysts on initial palpation. They are typically firm, well-circumscribed masses that may appear movable under the skin — characteristics that can falsely reassure owners. A fine needle aspirate (FNA) or biopsy is the only way to distinguish a soft tissue sarcoma from a harmless lump.
Recognizing the Symptoms: Early Warning Signs vs. Advanced Disease
Soft tissue sarcomas are notorious for being "silent" in early stages. Most dogs show no systemic illness when the tumor is small. Here is what to watch for, organized by disease progression:
| Stage | Symptoms | What It Looks Like |
|---|---|---|
| Early (Low Suspicion) | Single firm lump under the skin | Round or oval mass, 1–3 cm, often on trunk or limbs; may feel like a marble under the skin |
| Early | Slowly growing mass | Noticeable size increase over weeks to months; some remain stable for extended periods |
| Early | Painless to touch | Dog does not react when the area is palpated; no signs of discomfort |
| Moderate | Mass becomes fixed to underlying tissue | No longer freely movable; feels anchored to muscle or fascia beneath |
| Moderate | Rapid growth phase | Tumor doubles in size within days to weeks, sometimes after a long period of stability |
| Moderate | Localized swelling or inflammation | Area around the mass becomes warm, slightly red, or edematous |
| Advanced | Ulceration or open wound on mass | Skin over tumor breaks down; may ooze, bleed, or become infected |
| Advanced | Lameness or mobility issues | Tumor impinges on nerves, muscles, or joints (common with limb tumors) |
| Advanced | Pain on palpation | Dog vocalizes, pulls away, or guards the area when touched |
| Advanced | Weight loss and lethargy | Systemic signs indicating possible metastasis or cancer cachexia |
| Advanced | Difficulty breathing | Suggests lung metastasis — the most common distant spread site for STS |
Key insight: The most common mistake owners make is assuming a lump is a lipoma because it feels soft and movable. Many low-grade soft tissue sarcomas mimic lipomas for months. The American Kennel Club recommends that every new lump be evaluated by a veterinarian, regardless of how benign it appears.
Risk Factors: Which Dogs Are Most Vulnerable?
Soft Tissue Sarcoma Risk Factor Profile
- Age: Most common in middle-aged to older dogs (median age 8–10 years); rare in dogs under 3
- Breed predisposition: Golden Retrievers, Labrador Retrievers, German Shepherds, Rottweilers, Boxers, and mixed-breed large dogs show higher incidence
- Body weight: Dogs over 40 lb (18 kg) are overrepresented; large and giant breeds at elevated risk
- Sex: No strong sex predilection; some studies suggest slight male predisposition for certain subtypes
- Previous trauma or inflammation: Injection-site sarcomas (rare in dogs compared to cats) and tumors arising at sites of prior injury or surgical implants have been documented
- Genetics: No single gene identified, but breed clustering suggests heritable components in certain lineages
- Environment: No definitive environmental carcinogen linked, though general cancer risk factors (secondhand smoke, pesticide exposure) may contribute
Which Breeds Are Prone to Soft Tissue Sarcoma?
While any dog can develop a soft tissue sarcoma, veterinary oncology literature consistently identifies these breeds as overrepresented:
| Breed | Notable STS Subtypes | Notes |
|---|---|---|
| Golden Retriever | Fibrosarcoma, hemangiopericytoma | High overall cancer predisposition; STS among top concerns |
| Labrador Retriever | Fibrosarcoma, PNST | Common on limbs and trunk |
| German Shepherd | Hemangiopericytoma, fibrosarcoma | Higher-grade tumors reported in some studies |
| Rottweiler | Soft tissue sarcoma (various) | Elevated cancer mortality overall |
| Boxer | Fibrosarcoma, undifferentiated sarcoma | Prone to multiple tumor types |
| Rhodesian Ridgeback | Mast cell tumors, STS | Dermoid sinus may complicate presentation |
| Mixed breeds (large) | Various subtypes | Size appears to be a stronger risk factor than breed alone |
How Is Soft Tissue Sarcoma Diagnosed in Dogs?
Diagnosing STS follows a structured process. Your veterinarian will typically move through these steps, escalating as needed:
Diagnostic Process Flowchart
- Physical Examination & Lump Assessment
Vet palpates the mass, notes size, location, consistency, mobility, and checks regional lymph nodes. Cost: $50–$100 (exam fee). - Fine Needle Aspirate (FNA)
A thin needle extracts cells from the mass for cytology. This is the first-line diagnostic test. FNA can identify sarcoma-type cells but may not determine exact subtype or grade. Cost: $75–$200.
Note: Up to 20% of FNA samples from STS are non-diagnostic because these tumors shed cells poorly. A non-diagnostic FNA does NOT mean the lump is benign. - Incisional or Excisional Biopsy
If FNA is inconclusive or suggests sarcoma, a tissue biopsy provides definitive diagnosis and histologic grade (I, II, or III). Cost: $200–$600 (procedure) + $150–$350 (pathology lab fees). - Staging — Chest Radiographs (3-view)
Three X-ray views of the chest check for lung metastasis, the most common distant spread site. Cost: $250–$500. - Staging — Abdominal Ultrasound
Evaluates internal organs (liver, spleen, kidneys) for metastatic disease. Cost: $350–$650. - Advanced Imaging (CT or MRI)
Recommended for surgical planning, especially for tumors on limbs, the head, or near critical structures. CT provides precise tumor margins and involvement of underlying bone or fascia. Cost: $800–$2,500 depending on facility and region. - Complete Blood Count (CBC) & Chemistry Panel
Baseline health assessment before anesthesia and treatment. Cost: $120–$250.
Total diagnostic cost range: Expect to spend $800–$2,000 for a complete workup (exam, FNA, biopsy, staging imaging, blood work). Advanced imaging (CT/MRI) can push the total to $3,000–$4,500.
Understanding Tumor Grading
After biopsy, the pathologist assigns a histologic grade that directly informs prognosis and treatment decisions:
| Grade | Cell Characteristics | Metastatic Rate | Recurrence Risk (after incomplete surgery) |
|---|---|---|---|
| Grade I (Low) | Well-differentiated, slow-dividing cells | <10% | ~10–25% |
| Grade II (Intermediate) | Moderately differentiated, variable mitotic rate | 10–20% | ~25–45% |
| Grade III (High) | Poorly differentiated, high mitotic activity, necrosis | 25–50% | ~50–75% |
The majority of soft tissue sarcomas diagnosed in dogs are Grade I or II. High-grade (Grade III) tumors are less common but require more aggressive treatment.
Treatment Options: Surgery, Radiation, and Beyond
Soft tissue sarcoma treatment in dogs is multimodal — meaning the best outcomes usually come from combining therapies. Your veterinary oncologist will tailor the plan based on tumor grade, size, location, and staging results.
Can Soft Tissue Sarcoma Be Cured?
For low-to-intermediate grade tumors that are caught early and surgically removed with clean margins, long-term control — effectively a functional cure — is achievable. Many dogs with Grade I STS live out their normal lifespan after complete excision. However, "cure" is a complex term in oncology. High-grade tumors or those with metastasis at diagnosis carry a guarded prognosis, and treatment shifts toward extending quality life rather than elimination.
| Treatment | Best For | Success Rate / Outcome | Estimated Cost (2026) | Side Effects |
|---|---|---|---|---|
| Wide Surgical Excision | All grades; first-line treatment | Clean margins: 80–90% local control for Grade I/II; recurrence 10–25% | $1,500–$5,000 (varies by location and complexity) | Pain, infection risk, wound dehiscence, possible need for skin grafts or reconstruction |
| Radiation Therapy (definitive) | Incomplete margins, non-resectable tumors, Grade II/III | Local control rates 70–85% when combined with surgery; daily treatments over 3–4 weeks | $4,000–$8,000 (full course at specialty center) | Skin irritation, hair loss at site, mucositis (if near mouth), fatigue during treatment |
| Metronomic Chemotherapy | Post-surgery adjunct, especially Grade II/III; anti-angiogenic effect | Delays recurrence; typically cyclophosphamide + NSAID (piroxicam); ongoing daily oral treatment | $100–$300/month (medication) | Sterile hemorrhagic cystitis (cyclophosphamide), GI upset, kidney monitoring needed |
| Conventional Chemotherapy (Doxorubicin) | Grade III tumors, known metastasis | Response rate ~25–40% for measurable disease; may extend survival 3–6 months | $3,000–$6,000 (6-dose protocol) | Bone marrow suppression, cardiotoxicity (cumulative), GI signs, appetite loss |
| Electrochemotherapy | Superficial, non-resectable tumors; emerging option | Local control ~60–80% in published studies; limited availability | $1,500–$3,500 per session | Local tissue swelling, temporary pain at site |
| Palliative / Supportive Care | Advanced metastatic disease, owners declining aggressive treatment | Focuses on quality of life; pain management, anti-inflammatories, appetite support | $50–$300/month | Varies by medications used |
Surgical Margins: The Most Critical Factor
For soft tissue sarcomas, the single most important predictor of recurrence is whether the surgeon achieves clean (complete) margins — meaning no tumor cells are found at the edges of the removed tissue. Veterinary surgical oncology guidelines recommend lateral margins of 2–3 cm and at least one fascial plane deep. In practice, achieving these margins is challenging on distal limbs or the head, where tissue is limited. This is why CT imaging before surgery is so valuable — it lets the surgeon plan precisely.
If margins come back "dirty" (incomplete), your options include:
- Re-excision surgery (second surgery to remove more tissue)
- Radiation therapy to the surgical site
- Combination of both
- Active monitoring (acceptable for some Grade I tumors with narrowly incomplete margins)
Prognosis and Life Expectancy: What to Realistically Expect
Prognosis for soft tissue sarcoma in dogs depends heavily on grade, margin status, and whether metastasis is present at diagnosis. Here are evidence-based survival estimates:
| Scenario | Median Survival Time | 1-Year Survival | 2-Year Survival |
|---|---|---|---|
| Grade I, complete surgical margins | >3–4 years (many die of unrelated causes) | >90% | >85% |
| Grade II, complete margins | 2–4 years | 80–90% | 65–80% |
| Grade II, incomplete margins + radiation | 2–3 years | 75–85% | 60–75% |
| Grade III, surgery alone | 6–14 months | 50–65% | 25–40% |
| Grade III, surgery + chemotherapy | 10–18 months | 60–75% | 35–50% |
| Any grade with metastasis at diagnosis | 4–8 months (varies widely) | 30–50% | <20% |
What is the life expectancy of a dog with soft tissue sarcoma? For the most common scenario — a Grade I or II tumor caught before it spreads and removed with clean margins — most dogs live a normal or near-normal lifespan. The median survival times above reflect large study populations; individual outcomes vary based on your dog's overall health, tumor location, and response to treatment. According to data reviewed by the American Veterinary Medical Association, early detection remains the single biggest factor in positive outcomes.
Home Care and Daily Management After Diagnosis
Whether your dog is recovering from surgery, undergoing radiation, or being managed palliatively, home care plays a major role in their quality of life. Here is what daily management looks like:
Post-Surgical Care (First 2–3 Weeks)
- Incision monitoring: Check the surgical site twice daily for redness, swelling, discharge, or opening. Photograph daily to track healing.
- E-collar (cone): Essential for 10–14 days to prevent licking. If your dog cannot tolerate a traditional cone, ask your vet about inflatable collars or recovery suits — but never leave the incision unprotected.
- Activity restriction: Leash walks only for 10–14 days. No running, jumping, or rough play. For limb surgeries, crate rest or confined space may be necessary.
- Pain management: Administer prescribed medications (typically NSAIDs like carprofen or meloxicam, sometimes gabapentin or tramadol) on schedule. Do not wait for your dog to "show pain" — dogs mask discomfort instinctively.
- Follow-up: Suture removal at 10–14 days; pathology results typically available within 5–7 business days.
Long-Term Monitoring (Ongoing)
- Re-staging chest X-rays: Every 3–6 months for the first 2 years, then every 6–12 months. This catches lung metastasis early when intervention is still possible.
- Local site checks: Palpate the surgical area weekly for any new firmness, swelling, or masses that could indicate local recurrence.
- Weight management: Maintain a body condition score (BCS) of 4–5 out of 9. Obesity creates chronic inflammation that may promote tumor growth.
- Nutrition: Feed a complete and balanced diet (AAFCO-certified). Some oncologists recommend diets higher in omega-3 fatty acids (EPA/DHA) for their anti-inflammatory properties. Consult a veterinary nutritionist before making significant dietary changes.
Quality of Life Assessment
For dogs with advanced or metastatic STS, use a structured quality of life scale such as the HHHHHMM Scale (Hurt, Hunger, Hydration, Hygiene, Happiness, Mobility, More good days than bad). Score each category daily from 1–10. When bad days consistently outnumber good days, or when pain cannot be controlled with medication, it may be time to discuss humane euthanasia with your veterinarian.
How Much Does Soft Tissue Sarcoma Treatment Cost?
Cancer treatment costs are a legitimate concern for most dog owners. Here is a realistic breakdown based on 2026 veterinary pricing at specialty centers and general practices across the United States:
| Service | Low Estimate | High Estimate | Notes |
|---|---|---|---|
| Initial exam + FNA | $125 | $300 | General practice; may be higher at specialty |
| Biopsy + pathology | $350 | $950 | Incisional vs. excisional; lab fees vary |
| Staging (X-rays + ultrasound + blood work) | $700 | $1,400 | 3-view chest rads, abdominal US, CBC/chem |
| CT scan (if needed) | $800 | $2,500 | With contrast; university vs. private specialty |
| Surgical excision | $1,500 | $5,000 | Simple vs. complex location; reconstruction adds cost |
| Radiation therapy (definitive, 15–20 fractions) | $4,000 | $8,000 | Requires multiple anesthetics; only at specialty centers |
| Metronomic chemotherapy (6 months) | $600 | $1,800 | Oral cyclophosphamide + piroxicam; monthly monitoring |
| Conventional chemo (doxorubicin, 6 doses) | $3,000 | $6,000 | IV administration; pre-treatment labs each visit |
| Re-staging (every 3–6 months) | $300 | $700 | Chest X-rays + exam per visit |
Typical total cost scenarios:
- Best case (Grade I, clean margins, no adjunct therapy): $2,500–$5,000 total (diagnosis + surgery + first year of monitoring)
- Intermediate case (Grade II, incomplete margins, radiation): $8,000–$15,000 total
- Complex case (Grade III, surgery + chemo + ongoing care): $12,000–$22,000+ total
Pet insurance note: If your policy was active before the lump was discovered and STS is not a pre-existing condition exclusion, most comprehensive pet insurance plans cover 70–90% of oncology costs after deductible. Annual maximums of $10,000–$30,000 are common. Review your policy's oncology coverage before making treatment decisions.
When to See the Vet: Red Flag Symptoms
🚨 Call Your Veterinarian Immediately If:
- You discover any new lump or mass — especially if it is firm, growing, or attached to underlying tissue. Early evaluation is critical.
- An existing lump rapidly increases in size over days to weeks.
- A mass becomes ulcerated, bleeding, or infected (pus, foul odor, open wound).
- Your dog develops sudden lameness without obvious injury, particularly if a mass is present on the affected limb.
- Your dog shows difficulty breathing, persistent coughing, or exercise intolerance — possible signs of lung metastasis.
- Your dog has unexplained weight loss, appetite decline, or lethargy lasting more than 48 hours.
- Your dog is in obvious pain — vocalizing, panting at rest, unable to settle, or guarding a body area.
Do not wait. Soft tissue sarcomas are more treatable when small and localized. Every week of delay can mean a more complex surgery and higher risk of incomplete margins.
Prevention: What You Can (and Cannot) Control
There is no guaranteed way to prevent soft tissue sarcoma in dogs. Unlike some cancers linked to specific causes (e.g., hemangiosarcoma and certain environmental exposures, or mammary tumors and intact reproductive status), STS arises from complex genetic and cellular factors that are not fully understood.
However, you can reduce overall cancer risk and improve early detection odds:
- Monthly full-body "lump checks": Run your hands over your dog's entire body — neck, chest, belly, legs, tail base, between toes — once a month. Note any new masses and measure existing ones with a ruler. Document changes in a notebook or phone app.
- Maintain healthy weight: Chronic obesity promotes systemic inflammation and has been associated with increased cancer risk across multiple studies. Keep your dog at a BCS of 4–5/9.
- Limit known carcinogen exposure: Avoid tobacco smoke exposure, minimize pesticide and herbicide contact (wipe paws after walks on treated lawns), and reduce unnecessary exposure to diagnostic radiation (while not avoiding medically necessary imaging).
- Regular veterinary wellness exams: Twice-yearly checkups for dogs over age 7 allow your vet to catch masses early, often before you notice them at home.
- Consider breed-appropriate genetic screening: While no specific STS gene test exists, general health screening (hips, cardiac, thyroid) helps you understand your dog's overall health profile, which is relevant if cancer treatment becomes necessary.
Frequently Asked Questions
What is the difference between a soft tissue sarcoma and a lipoma?
Lipomas are benign fatty tumors that are soft, freely movable, and do not invade surrounding tissue. Soft tissue sarcomas can feel similar on initial palpation but tend to be firmer, may become fixed to underlying tissue over time, and grow invasively. The only reliable way to tell them apart is through fine needle aspirate (FNA) or biopsy. Many veterinarians recommend aspirating every "lipoma" at least once, especially in breeds predisposed to STS, because some sarcomas are clinically indistinguishable from lipomas by feel alone.
Is soft tissue sarcoma painful for dogs?
In early stages, most soft tissue sarcomas are painless, which is one reason they go undetected. As tumors grow and invade nerves, muscle, or bone, they can become painful. Ulcerated or infected tumors are typically uncomfortable. Post-surgical pain is managed with multimodal analgesia (NSAIDs, gabapentin, sometimes opioids for the first 48–72 hours). If your dog is limping, guarding an area, or showing behavioral changes like irritability or reluctance to be handled, pain should be assumed and addressed.
How fast does soft tissue sarcoma grow in dogs?
Growth rates vary enormously. Low-grade (Grade I) tumors may grow imperceptibly over many months or even remain stable for a year or more. High-grade (Grade III) tumors can double in size within weeks. Some owners report a tumor that was "stable" for months suddenly entering a rapid growth phase — this is a known behavior pattern and one reason consistent monitoring is essential even for masses that have been previously evaluated.
Should I see a veterinary oncologist or can my regular vet handle this?
Your general practice veterinarian is well-equipped to perform the initial workup (exam, FNA, staging X-rays). If the diagnosis is confirmed as STS, referral to a veterinary oncologist (DACVIM-Oncology) and/or a veterinary surgeon (DACVS) is recommended for treatment planning, especially for Grade II/III tumors, tumors in challenging locations, or if radiation therapy is being considered. Many general practitioners collaborate with specialists via telemedicine consults if a referral center is not nearby.
Can soft tissue sarcoma spread to other dogs or to humans?
No. Soft tissue sarcoma is not contagious. It cannot be transmitted to other dogs, to cats, or to humans. Cancer is a disease of the individual animal's own cells and is not zoonotic.
What are the signs that treatment is no longer working?
Key indicators that a treatment plan may need to change or that palliative transition is appropriate include: local tumor recurrence despite surgery and radiation, new lung nodules on re-staging X-rays, declining body condition despite supportive care, pain that is no longer controlled with medication, and a consistent pattern of more bad days than good days on quality of life assessments. Your veterinary oncologist will help you navigate these decisions with compassion and clinical data.
Tom Renshaw
All our authors care for dogs every day — read more of their work on the authors page.



